直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Prosecution First Blog

Preissuance Submission: What, Who, When, and How

April 10, 2013

Authored and Edited by Adriana L. Burgy; Jeffrey A. Berkowitz

What?

  • A third party, anonymously, may file any patents, published patent applications, or other printed publications of potential relevance to the examination of a patent application.
  • May be filed in any non-provisional utility, design, or plant application, and any continuing application.
  • Cannot be filed in a reissue application, a reexamination proceeding, or an issued patent.

Who?

  • Any member of the public may file.
  • A person or entity with a duty of disclosure under 37 C.F.R. § 1.56 may NOT file in the application of interest.

When?

  • File before the earlier of: (1) a Notice of Allowance or (2) the later of either (a) six-months after publication of the application or (b) the first rejection of the application.
    • Notice of Allowance issued ≠ preissuance submission
    • If Notice of Allowance has yet to issue, look to the date of publication of the application.If you are 6-months past the publication date, look to determine if a first office action issued. One can file as long as the application has not been published for six-months or the first rejection has not been issued.
  • No extensions of time are available.
  • All submissions must be filed prior to, not on, the outlined dates.

How?

  • Submission must include:
    • Document list identifying the publications, or portions of publications submitted.
    • Concise description of the asserted relevance of each item identified in the document list.
      • Set forth facts and explain how an item is of potential relevance; no arguments or conclusions regarding patentability.
      • Example formats: a narrative or claim chart.
    • Copy of those items listed on the document list, other than U.S. patents and U.S. patent application publications.
    • English language translation of any non-English language document.
    • Statement by the party making the submission that:
      • The party is not an individual who has a duty to disclose information with respect to the application under 37 C.F.R. §1.56; and
      • The submission complies with the requirements of 35 U.S.C. §122(e) and 37 C.F.R. §1.290.
    • Required fee or a statement regarding the fee exemption.
      • Required fee for every ten documents listed or fraction thereof.
      • Fee exemption for three or fewer documents, as long as it’s the party’s first submission and a “first and only” statement is included.
      • Small entity discount; no micro-entity discount.

Tags

patent application, preissuance submission, Third-Party Submissions, United States Patent and Trademark Office (USPTO)

Contacts

Adriana L. Burgy
Partner
Washington, DC
+1 202 408 4345
Email
Jeffrey A. Berkowitz
Partner
Reston, VA
+1 571 203 2710
Email

Copyright © 2013 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. Additional disclaimer information. 

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

Best Practices and Tech in Intellectual Property Conference 2026

May 17, 2026

Tel Aviv

Articles

COPPA’s Amended Rule Is Now in Full Effect: What Operators Need to Know

May 15, 2026

Seminar

IP Strategy at the Crossroads: Technology, Enforcement, and Contracts

May 15, 2026

Taipei

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP